CIK 0001727196 · Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823750435
- Phone
- 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-02 | Vaishnaw Akshay President of R&D | Grant or award · Stock Option (Right to Buy) | +110,067 | 110,067 | ||
| 2025-05-02 | Sinha Vikas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +110,067 | 110,067 | ||
| 2025-05-02 | Hallal David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +275,167 | 275,167 | ||
| 2025-04-27 | Woods Keith Chief Operating Officer | Grant or award | +100,000 | 100,000 | ||
| 2025-04-27 | Woods Keith Chief Operating Officer | Grant or award | +500,000 | 600,000 | ||
| 2025-04-27 | Vaishnaw Akshay President of R&D | Grant or award | +100,000 | 122,955 | ||
| 2025-04-27 | Vaishnaw Akshay President of R&D | Grant or award | +500,000 | 622,955 | ||
| 2025-04-27 | Hallal David CEO | Grant or award | +250,000 | 554,095 | ||
| 2025-04-27 | Hallal David CEO | Grant or award | +1,250,000 | 1,804,095 | ||
| 2025-04-27 | Sinha Vikas Chief Financial Officer | Grant or award | +100,000 | 100,000 | ||
| 2025-04-27 | Sinha Vikas Chief Financial Officer | Grant or award | +500,000 | 600,000 | ||
| 2025-04-25 | Sacco Tracey Chief Commercial Officer | Option exercise 10b5-1 | +5,000 | $10.00 | $50K | 76,250 |
| 2025-04-25 | Sacco Tracey Chief Commercial Officer | Sale 10b5-1 | −4,916 | $32.81 | $161K | 71,834 |
| 2025-04-25 | Sacco Tracey Chief Commercial Officer | Sale 10b5-1 | −84 | $33.49 | $3K | 71,750 |
| 2025-04-25 | Sacco Tracey Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 185,000 | ||
| 2025-03-24 | Sacco Tracey Chief Commercial Officer | Option exercise 10b5-1 | +5,000 | $10.00 | $50K | 78,250 |
| 2025-03-24 | Sacco Tracey Chief Commercial Officer | Sale 10b5-1 | −1,500 | $33.70 | $51K | 76,750 |
| 2025-03-24 | Sacco Tracey Chief Commercial Officer | Sale 10b5-1 | −5,000 | $32.89 | $164K | 71,750 |
| 2025-03-24 | Sacco Tracey Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 190,000 | ||
| 2025-03-24 | Moore Erin Interim PFO and PAO | Option exercise 10b5-1 | +5,000 | $23.86 | $119K | 87,609 |
Page 9 of 12 · 227 trades